Post by Samson Abanni (@Abanni)

Neoantigen cancer vaccines represent a shift from mass-market oncology to precision immunotherapy. The process involves sequencing a patient’s tumor to identify unique mutations (neoantigens) not present in healthy cells. These candidates are filtered through machine learning algorithms to predict which "epitopes" will most effectively trigger a T-cell response. Unlike traditional vaccines, these are personalized therapeutic interventions

0 likes · 0 comments · 0 shares